VivoSim Labs (VIVS) Cash from Financing Activities (2010 - 2026)
VivoSim Labs (VIVS) posted Cash from Financing Activities of -$118000.0 for Q2 2026, down 104.1% on a QoQ basis from $2.9 million in Q1 2026, and down 107.01% year-over-year from $1.7 million in Q2 2025.
Powered by 
Analysis
VivoSim Labs (VIVS) Cash from Financing Activities (2010 - 2026) Analysis & Trends
VivoSim Labs has reported Cash from Financing Activities for 16 years, with the latest figure at -$118000.0 in Q2 2026.
- On a quarterly basis, Cash from Financing Activities fell 107.01% year-over-year to -$118000.0 in Q2 2026; TTM through Jun 2026 was $2.6 million, a 38.24% decrease from a year earlier, with the FY2026 full-year figure at $4.4 million, down 49.76% from the prior year.
- Cash from Financing Activities was -$118000.0 for Q2 2026 at VivoSim Labs, down from $2.9 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $6.2 million in Q2 2024, with the low at -$371000.0 in Q3 2024.
- Average Cash from Financing Activities over 4 years is $1.5 million, with a median of $718500.0 recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities plunged 118.41% in 2024, then surged 1106.44% in 2025.
- Over 4 years, Cash from Financing Activities stood at $1.2 million in 2023, then slumped by 118.41% to -$216000.0 in 2024, then surged by 45.37% to -$118000.0 in 2025, then changed by 0.0% to -$118000.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$118000.0 (Q2 2026), $2.9 million (Q1 2026), and -$118000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -214.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -288.34 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -8.12 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -164.66 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 16.49 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 33,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 248,151.59 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -118,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -118,000.00 |
| Mar 31, 2026 | 2.88 Mn |
| Dec 31, 2025 | -118,000.00 |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 3.19 Mn |
| Dec 31, 2024 | -216,000.00 |
| Sep 30, 2024 | -371,000.00 |
| Jun 30, 2024 | 6.25 Mn |
| Mar 31, 2024 | 264,000.00 |
| Dec 31, 2023 | 1.17 Mn |
| Dec 31, 2021 | -1,000.00 |
| Sep 30, 2021 | -45,000.00 |
| Jun 30, 2021 | 251,000.00 |
| Mar 31, 2021 | 20.75 Mn |
| Dec 31, 2020 | 3.07 Mn |
| Sep 30, 2020 | 12,000.00 |
| Jun 30, 2020 | -1,000.00 |
| Dec 31, 2019 | -1,000.00 |
| Sep 30, 2019 | -8,000.00 |
| Jun 30, 2019 | 4.94 Mn |